Published in Histochem Cell Biol on January 26, 2008
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55
Mutation of sec63 in zebrafish causes defects in myelinated axons and liver pathology. Dis Model Mech (2012) 0.86
Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. PLoS One (2012) 0.82
Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells. Stem Cell Res Ther (2015) 0.80
State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology. Histochem Cell Biol (2008) 0.75
The uterine expression of SEC63 gene is up-regulated at implantation sites in association with the decidualization during the early pregnancy in mice. Reprod Biol Endocrinol (2009) 0.75
Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions. J Bioenerg Biomembr (2016) 0.75
Extending the knowledge in histochemistry and cell biology. Histochem Cell Biol (2009) 0.75
The primary cilium as the cell's antenna: signaling at a sensory organelle. Science (2006) 6.79
Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature (1997) 4.40
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. Gastroenterology (2006) 2.68
Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol (2000) 2.66
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology (2006) 2.61
Subcellular fractionation of rat liver. Methods Enzymol (1974) 2.53
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet (2004) 2.47
The cholangiopathies: disorders of biliary epithelia. Gastroenterology (2004) 2.38
Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol (1985) 2.18
Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet (2004) 1.96
Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol (1999) 1.59
Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction. Biochem J (2000) 1.58
Overexpression of PKD1 causes polycystic kidney disease. Mol Cell Biol (2006) 1.47
Mammalian Sec61 is associated with Sec62 and Sec63. J Biol Chem (2000) 1.47
A "two-hit" model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med (2001) 1.47
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A (1996) 1.40
Clinical profile of autosomal dominant polycystic liver disease. Hepatology (2003) 1.37
Quaternary and domain structure of glycoprotein processing glucosidase II. Biochemistry (2001) 1.15
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. Am J Pathol (2000) 1.11
Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Hum Mutat (2006) 1.10
Immunolocalization of the oligosaccharide trimming enzyme glucosidase II. J Cell Biol (1986) 1.07
Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: an autopsy study. Hepatology (1992) 1.05
The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo. Glycobiology (2000) 1.00
Massive hepatomegaly in adult polycystic liver disease. Am J Surg Pathol (1988) 1.00
Molecular characterization of a novel mammalian DnaJ-like Sec63p homolog. Biol Chem (1999) 0.98
Expression of neural cell adhesion molecule in human liver development and in congenital and acquired liver diseases. Histochem Cell Biol (2001) 0.97
80K-H as a new Ca2+ sensor regulating the activity of the epithelial Ca2+ channel transient receptor potential cation channel V5 (TRPV5). J Biol Chem (2004) 0.95
Adult polycystic liver and kidney diseases are separate entities. Clin Genet (1986) 0.94
Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. Gastroenterology (2004) 0.93
Cell type-specific post-Golgi apparatus localization of a "resident" endoplasmic reticulum glycoprotein, glucosidase II. J Cell Biol (1990) 0.83
Multiple cysts in the liver autosomal dominant polycystic liver disease. Neth J Med (2006) 0.81
Elevated 80K-H protein in breast cancer: a role for FGF-1 stimulation of 80K-H. Int J Biol Markers (2003) 0.80
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet (2008) 4.44
Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol (2002) 4.02
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med (2013) 3.81
Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol (2011) 3.53
Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol (2002) 3.09
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol (2005) 2.52
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2007) 2.48
Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. J Cell Biol (2006) 2.41
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2009) 2.33
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci U S A (2009) 2.32
Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Hepatology (2014) 2.27
Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol (2002) 2.11
NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol (2004) 1.90
Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A (2010) 1.79
Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial. J Hepatol (2013) 1.79
Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey. Intensive Care Med (2003) 1.76
Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) (2008) 1.74
The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol (2003) 1.68
Short mucin 6 alleles are associated with H pylori infection. World J Gastroenterol (2006) 1.67
Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol (2010) 1.67
Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data. Gastroenterology (2013) 1.66
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol (2012) 1.58
Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease. Gastroenterology (2011) 1.58
A role for the small GTPase Rab21 in the early endocytic pathway. J Cell Sci (2004) 1.57
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol (2007) 1.50
Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol (2004) 1.48
Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol (2013) 1.46
No beneficial effects of amantadine in treatment of chronic hepatitis C patients. Dig Liver Dis (2009) 1.46
Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol (2007) 1.45
Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis. J Mol Diagn (2012) 1.44
Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites. Leuk Lymphoma (2013) 1.43
Evaluation of hepatic cystic lesions. World J Gastroenterol (2013) 1.43
Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod Pathol (2003) 1.42
The ileo neo rectal anastomosis: long-term results of surgical innovation in patients after ulcerative colitis and familial adenomatous polyposis. Int J Colorectal Dis (2012) 1.38
Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer (2006) 1.38
Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics (2005) 1.34
Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature. Dig Dis Sci (2009) 1.34
Deletion mutation of sodium channel Na(V)1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability. Brain (2011) 1.32
Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int (2011) 1.30
Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol (2002) 1.30
Beneficial response to interleukin 1 receptor antagonist in traps. Am J Med (2004) 1.29
2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol (2005) 1.26
Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci U S A (2009) 1.25
Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis (2005) 1.24
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther (2004) 1.23
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis (2012) 1.21
Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer (2009) 1.20
Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry. Leuk Lymphoma (2013) 1.16
Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli. Immunology (2007) 1.12
Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int (2007) 1.11
Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. Am J Clin Pathol (2006) 1.10
Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Hum Mutat (2006) 1.10
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet (2011) 1.09
Proliferation of authors on research reports in medicine. Sci Eng Ethics (1996) 1.09
Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol Pain (2011) 1.09
The dendritic cell-derived protein DC-STAMP is highly conserved and localizes to the endoplasmic reticulum. J Leukoc Biol (2004) 1.09
Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat (2011) 1.07
Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer (2011) 1.07
Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease. J Hepatol (2009) 1.06
Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int (2009) 1.05
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol (2005) 1.04
Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia. Brain (2010) 1.04
Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res (2007) 1.04
HCV treatment--no more room for interferonologists? N Engl J Med (2013) 1.03
Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. J Biol Chem (2008) 1.03
Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome. Blood (2006) 1.02
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
A role for the Rab6B Bicaudal-D1 interaction in retrograde transport in neuronal cells. Exp Cell Res (2007) 1.02
Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res (2007) 1.01
Somatostatin analogues for treatment of polycystic liver disease. Curr Opin Gastroenterol (2011) 1.01
Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis. Proc Natl Acad Sci U S A (2014) 1.00
Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg (2007) 0.98
Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol (2008) 0.97
Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res (2010) 0.96
Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res (2006) 0.96
High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk. Int J Oncol (2012) 0.95
GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology. Eur J Cancer Prev (2013) 0.95
Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology (2013) 0.94
Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging (2002) 0.94
Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica (2013) 0.94
Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy. Clin Cancer Res (2007) 0.93
Fully automated assessment of inflammatory cell counts and cytokine expression in bronchial tissue. Am J Respir Crit Care Med (2003) 0.93
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging (2004) 0.93
Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons. Nat Rev Neurol (2010) 0.93
Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol (2010) 0.92
t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma. Genes Chromosomes Cancer (2006) 0.92
Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics. Genetics (2005) 0.92
Familial Mediterranean fever--a not so unusual cause of abdominal pain. Best Pract Res Clin Gastroenterol (2005) 0.92
PTPRR protein tyrosine phosphatase isoforms and locomotion of vesicles and mice. Cerebellum (2009) 0.91
Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk. Int J Cancer (2013) 0.91
Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. J Mol Med (Berl) (2006) 0.91
Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. Liver Int (2007) 0.91